A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy

Pain

Volumn 155, Issue 10, 2014, Pages 1943-1954

  Simpson, David M ^a   Rice, Andrew S C ^b,c   Emir, Birol ^d   Landen, Jaren ^d   Semel, David ^d   Chew, Marci L ^d   Sporn, Jonathan ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d PFIZER INC   (United States)

Author keywords

HIV; Polyneuropathy; Pregabalin; Randomized controlled trial

Indexed keywords

PREGABALIN; ANALGESIC AGENT;

ACTIMETRY; ADULT; AGED; ARTICLE; BACKACHE; BODY WEIGHT DISORDER; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISTAL SENSORY POLYNEUROPATHY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROENTERITIS; HEADACHE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION ASSOCIATED NEUROPATHY; INFLUENZA; INTENTION TO TREAT ANALYSIS; LIMIT OF QUANTITATION; LOWER LIMIT OF QUANTIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NEUROPATHIC PAIN; NUMERIC RATING SCALE; OPEN STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT AND CLINICIAN GLOBAL IMPRESSION OF CHANGE; PERIPHERAL EDEMA; PHARYNGITIS; POLYNEUROPATHY; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINOPHARYNGITIS; SENSITIVITY ANALYSIS; SHORT FORM 36; SINGLE BLIND PROCEDURE; SLEEP; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION; COMPLICATION; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; POLYNEUROPATHIES; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANALGESICS; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; POLYNEUROPATHIES; PREGABALIN; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908089295     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.05.027     Document Type: Article

References (45)

1. E. Anastassiou, C.A. Iatrou, N. Vlaikidis, M. Vafiadou, G. Stamatiou, E. Plesia, L. Lyras, and A. Vadalouca Impact of pregabalin treatment on pain, pain-related sleep interference and general well-being in patients with neuropathic pain: a non-interventional, multicentre, post-marketing study Clin Drug Invest 31 2011 417 426
2. B.D. Arasho, S.B. Jacob, and G. Zenebe Distal symmetric polyneuropathy and toxic neuropathy in HIV patients Ann Trop Med Public Health 3 2010 8 13
3. D. Bouhassira, N. Attal, J. Fermanian, H. Alchaar, M. Gautron, E. Masquelier, S. Rostaing, M. Lanteri-Minet, E. Collin, J. Grisart, and F. Boureau Development and validation of the Neuropathic Pain Symptom Inventory PAIN® 108 2004 248 257
4. J. Boyle, M.E. Eriksson, L. Gribble, R. Gouni, S. Johnsen, D.V. Coppini, and D. Kerr Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life Diabetes Care 35 2012 2451 2458
5. M.S. Cepeda, J.A. Berlin, C.Y. Gao, F. Wiegand, and D.R. Wada Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis Pain Med 13 2012 575 595
6. R.L. Daut, C.S. Cleeland, and R.C. Flanery Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases PAIN® 17 1983 197 210
7. R.H. Dworkin, A.E. Corbin, J.P. Young Jr., U. Sharma, L. LaMoreaux, H. Bockbrader, E.A. Garofalo, and R.M. Poole Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial Neurology 60 2003 1274 1283
8. R.H. Dworkin, J. Katz, and M.J. Gitlin Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain Neurology 65 2005 S7 S19
9. R.H. Dworkin, D.C. Turk, S. Peirce-Sandner, R. Baron, N. Bellamy, L.B. Burke, A. Chappell, K. Chartier, C.S. Cleeland, A. Costello, P. Cowan, R. Dimitrova, S. Ellenberg, J.T. Farrar, J.A. French, I. Gilron, S. Hertz, A.R. Jadad, G.W. Jay, J. Kalliomaki, N.P. Katz, R.D. Kerns, D.C. Manning, M.P. McDermott, P.J. McGrath, A. Narayana, L. Porter, S. Quessy, B.A. Rappaport, C. Rauschkolb, B.B. Reeve, T. Rhodes, C. Sampaio, D.M. Simpson, J.W. Stauffer, G. Stucki, J. Tobias, R.E. White, and J. Witter Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations PAIN® 149 2010 177 193
10. R.H. Dworkin, D.C. Turk, K.W. Wyrwich, D. Beaton, C.S. Cleeland, J.T. Farrar, J.A. Haythornthwaite, M.P. Jensen, R.D. Kerns, D.N. Ader, N. Brandenburg, L.B. Burke, D. Cella, J. Chandler, P. Cowan, R. Dimitrova, R. Dionne, S. Hertz, A.R. Jadad, N.P. Katz, H. Kehlet, L.D. Kramer, D.C. Manning, C. McCormick, M.P. McDermott, H.J. McQuay, S. Patel, L. Porter, S. Quessy, B.A. Rappaport, C. Rauschkolb, D.A. Revicki, M. Rothman, K.E. Schmader, B.R. Stacey, J.W. Stauffer, T. von Stein, R.E. White, J. Witter, and S. Zavisic Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations J Pain 9 2008 105 121
11. R.J. Ellis, D. Rosario, D.B. Clifford, J.C. McArthur, D. Simpson, T. Alexander, B.B. Gelman, F. Vaida, A. Collier, C.M. Marra, B. Ances, J.H. Atkinson, R.H. Dworkin, S. Morgello, and I. Grant Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: The CHARTER Study Arch Neurol 67 2010 552 558
12. S. Ferrari, S. Vento, S. Monaco, T. Cavallaro, F. Cainelli, N. Rizzuto, and Z. Temesgen Human immunodeficiency virus-associated peripheral neuropathies Mayo Clin Proc 81 2006 213 219
13. R. Freeman, R. Baron, D. Bouhassira, J. Cabrera, and B. Emir Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs PAIN® 155 2014 367 376
14. Freynhagen R, Serpell M, Emir B, Whalen E, Parsons B, Clair A, Latymer M. A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain. Pain Practice; 2013. http://dx.doi.org/10.1111/papr.12146. [Epub ahead of print].
15. R. Freynhagen, K. Strojek, T. Griesing, E. Whalen, and M. Balkenohl Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens PAIN® 115 2005 254 263
16. W. Guy Assessment manual for psychopharmacology revised, N.P.R.B 1976 US Department of Health, Education and Welfare Rockville, MD
17. R.D. Hays, S.A. Martin, A.M. Sesti, and K.L. Spritzer Psychometric properties of the Medical Outcomes Study Sleep measure Sleep Med 6 2005 41 44
18. W. Huang, M. Calvo, K. Karu, H.R. Olausen, G. Bathgate, K. Okuse, D.L. Bennett, and A.S. Rice A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy PAIN® 154 2013 560 575
19. G. Irving The placebo response: relationship to outcomes in trials of postherpetic neuralgia Clin Drug Invest 30 2010 739 748
20. M.P. Jensen, and P. Karoly Self-report scales and procedures for assessing pain in adults D.C. Turk, R. Melzack, Handbook of pain assessment 1992 Guildford Press New York 134 151
21. J. Jose, K. Saravu, B. Jimmy, and B.A. Shastry Distal sensory polyneuropathy in human immunodeficiency virus patients and nucleoside analogue antiretroviral agents Ann Indian Acad Neurol 10 2007 81 87
22. J. Katz, N.B. Finnerup, and R.H. Dworkin Clinical trial outcome in neuropathic pain: relationship to study characteristics Neurology 70 2008 263 272
23. N. Katz Methodological issues in clinical trials of opioids for chronic pain Neurology 65 2005 S32 S49
24. K. Kieburtz, D. Simpson, C. Yiannoutsos, M.B. Max, C.D. Hall, R.J. Ellis, C.M. Marra, R. McKendall, E. Singer, G.J. Dal Pan, D.B. Clifford, T. Tucker, and B. Cohen A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team Neurology 51 1998 1682 1688
25. J. Koroschetz, S.E. Rehm, U. Gockel, M. Brosz, R. Freynhagen, T.R. Tolle, and R. Baron Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia BMC Neurol 11 2011 55
26. S.L. Letendre, R.J. Ellis, I. Everall, B. Ances, A. Bharti, and J.A. McCutchan Neurologic complications of HIV disease and their treatment Topics HIV Med 17 2009 46 56
27. A. Manas, J.P. Ciria, M.C. Fernandez, M.L. Gonzalvez, V. Morillo, M. Perez, X. Masramon, and V. Lopez-Gomez Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health Clin Transl Oncol 13 2011 656 663
28. P.K. Nicholas, L. Mauceri, A. Slate Ciampa, I.B. Corless, N. Raymond, D.J. Barry, and A. Viamonte Ros Distal sensory polyneuropathy in the context of HIV/AIDS J Assoc Nurses AIDS Care 18 2007 32 40
29. Pfizer Inc. LYRICA annex I: summary of product information (EU). Available at: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000546/WC500046602.pdf. Accessed June 6, 2014.
30. Pfizer Inc. LYRICA US prescribing information. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=561. Accessed June 6, 2014.
31. T.J. Phillips, C.L. Cherry, S. Cox, S.J. Marshall, and A.S. Rice Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials PLoS One 5 2010 e14433
32. S.N. Quessy, and M.C. Rowbotham Placebo response in neuropathic pain trials PAIN® 138 2008 479 483
33. G. Ramjee, N. Coumi, N. Dladla-Qwabe, S. Ganesh, S. Gappoo, R. Govinden, V. Guddera, R. Maharaj, J. Moodley, N. Morar, S. Naidoo, and T. Palanee Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa AIDS Res Ther 7 2010 10
34. J. Rosenstock, M. Tuchman, L. LaMoreaux, and U. Sharma Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial PAIN® 110 2004 628 638
35. M.C. Rowbotham The case for publishing 'negative' clinical trials PAIN® 146 2009 225 226
36. R. Sabatowski, R. Galvez, D.A. Cherry, F. Jacquot, E. Vincent, P. Maisonobe, and M. Versavel Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial PAIN® 109 2004 26 35
37. D.M. Simpson, J.C. McArthur, R. Olney, D. Clifford, Y. So, D. Ross, B.J. Baird, P. Barrett, and A.E. Hammer Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial Neurology 60 2003 1508 1514
38. D.M. Simpson, G. Schifitto, D.B. Clifford, T.K. Murphy, E. Durso-De Cruz, P. Glue, E. Whalen, B. Emir, G.N. Scott, and R. Freeman Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial Neurology 74 2010 413 420
39. H.S. Smith Treatment considerations in painful HIV-related neuropathy Pain Phys 14 2011 E505 E524
40. T. Tolle, R. Freynhagen, M. Versavel, U. Trostmann, and J.P. Young Jr. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study Eur J Pain 12 2008 203 213
41. UNAIDS: The Joint United Nations Programme on HIV. Global HIV/AIDS response - epidemic update and health sector progress towards universal access - progress report 2011. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20111130-ua-report-en.pdf. Accessed June 6, 2014.
42. R. van Seventer, H.A. Feister, J.P. Young Jr., M. Stoker, M. Versavel, and L. Rigaudy Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial Curr Med Res Opin 22 2006 375 384
43. Ware J, Kosinski M, Dewey J. How to score version 2 of the SF-36 Health Survey: standard and acute forms. Lincoln, RI: QualityMetric, Inc.; 2001.
44. F.L. Wilkie, C. Eisdorfer, R. Morgan, D.A. Loewenstein, and J. Szapocznik Cognition in early human immunodeficiency virus infection Arch Neurol 47 1990 433 440
45. A.S. Zigmond, and R.P. Snaith The Hospital Anxiety and Depression Scale Acta Psychiatr Scand 67 1983 361 370